It seems that a content is not there yet. If you don't mind, drop us a line on what you've been looking for via the form below, and we might add missing content in a couple of updates.
Up to 44 percent of papillary thyroid cancer patients have a B - raf mutation that can be specifically targeted by existing cancer drugs. (sciencedaily.com)
«Targeted therapies show initial effectiveness in subset of papillary thyroid cancer.» (sciencedaily.com)
The lesions evaluated in this study that can become cancerous are known as intraductal papillary mucinous neoplasms. (sciencedaily.com)